Servier closes acquisition of Danish antibody discovery company Symphogen
Servier has wrapped up its previously announced acquisition of Symphogen, a Danish antibody discovery company, for an undisclosed price. The French pharma company signed the deal in April 2020 with a bid to ramp up its antibody capabilities while ensuring that its own antibody discovery and early-development platform is completely leveraged. Through the acquisition, Servier will […]